Results 191 to 200 of about 1,575,773 (328)

Contrast-enhanced sonography in the examination of benign and malignant adnexal masses. [PDF]

, 2000
Maija‐Riitta Ordén, Sæmundur Gudmundsson, Pertti Kirkinen   +2 more
openalex   +1 more source

The influence of ROS1 fusion partners and resistance mechanisms in ROS1‐TKI‐treated non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga, Christa Dijkhuizen, Patrick Korthuis, Wim Timens, Harry Groen, Jeroen Hiltermann, Anke van den Berg, Lyndsay Drayer, Anthonie van der Wekken   +8 more
wiley   +1 more source

Micro-Gap Weld Seam Contrast Enhancement via Phase Contrast Imaging. [PDF]

Materials (Basel)
Yang Y, Yang Y, Shao W.
europepmc   +1 more source

Contrast-Enhanced Magnetic Resonance Angiography: Dose the Test Dose Bolus Represent the Main Dose Bolus Accurately? [PDF]

, 2000
Jongmin J. Lee, Yongmin Chang, Duk-Sik Kang   +2 more
openalex   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

Initial insights into post-contrast enhancement in ultra-low-field MRI: Case Report. [PDF]

Front Neuroimaging
Altaf A, Alam MS, Khan S, Azan A, Mubarak F, Knopp E, Siddiqui K, Enam SA.   +7 more
europepmc   +1 more source

Contrast enhancement in acoustic microscope [PDF]

, 1994
Kolosov, Oleg, OGISO, H, YAMANAKA, K
core  

A model for MRI contrast enhancement using T ₁ agents

, 1998
Eric T. Ahrens, Ute Rothbächer, Russell E. Jacobs, Scott E. Fraser   +3 more
openalex   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Feasibility Study of Triple-low CCTA for Coronary Artery Disease Screening Combining Contrast Enhancement Boost and Deep Learning Reconstruction. [PDF]

Rev Cardiovasc Med
Wu Z, Chen M, Wei Y, Shen C, Han W, Xu R, Zhou Z, Xu J.   +7 more
europepmc   +1 more source